EVERSANA, a leading provider of global commercial services to the life sciences industry, has announced two strategic ...

The announcement builds on AZ's announcement earlier this year that it will invest $2.5 billion in an R&D facility in China, ...

While Takeda's Qdenga (TAK-003) shot is approved as a two-dose regimen to protect people from the disease in dozens of ...

US Senators Bernie Sanders and Angus King have introduced a bill that seeks to ban direct-to-consumer (DTC) advertising by ...

The Health and Human Services (HHS) Secretary named eight hand-picked members of the Advisory Committee on Immunisation ...

A fourth revolution in cancer care is taking shape, one that steps away from the current well-trodden path. This revolution ...

Describing the current treatment landscape for primary and secondary bone cancer, Romness explains the potential of their own ...

Full results from the first phase 3 trial of UCB and Biogen's anti-CD40L antibody dapirolizumab pegol (DZP) in systemic lupus ...

England is the first country in the world to make GSK's anti-BCMA drug Blenrep available to patients with the haematological ...

Alpha-1 is a microcosm of the rare disease world. The challenges we face, late diagnoses, inconsistent care, and unaffordable ...

Type of data available on UK Pharmascan registration, with a breakdown on whether the live record is for a new indication, ...

As major pharmacy chains like Walgreens continue to close hundreds of stores nationwide, pharmacy deserts are increasing ...